Enjoy your project.
Synapse is a firm specialized in the high quality management of complex research and development projects in the biomedical sector.
Synapse partners with national and international organisations, both public and private. Our company goes beyond classical project management and brings in added value capabilities in team management, vision management, strategic thinking and project intelligence. Synapse’s expertise extends to market knowledge, business planning and valorization of research results.
Enjoy your project
We believe a research project should be an enjoyable experience for all partners.
Without ideas there is nothing to manage
For us a good scientific idea is the essential pillar and the origin for any successful and enjoyable project.
Partnership VS Service
We aim to provide an excellent personalized service, but we see ourselves as a committed partner – together we pursue mutual benefit.
Knowledge
Our structure is based on our broad experience and knowledge in the project management field.
Leveraging your leadership
Leading a complex research project with multiple stakeholders from a very diverse range of environments and countries is not an easy task.
OUR PROJECTS
-
ERA4TB
European Accelerator of Tuberculosis Regime The main objective of ERA4TB is to create a European open platform to... -
NEURONET
Efficiently Networking European Neurodegeneration Research The main aim of NEURONET is to set up an efficient platform to... -
TransBioLine
Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project To Enable Development And Implementation Of Novel Safety Biomarkers... -
HTx
Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health... -
EHDEN
European Health Data & Evidence Network The mission of EHDEN is to provide a new paradigm for the... -
eTRANSAFE
Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFE project aims to develop an advanced data integration infrastructure... -
Drive
Development of Robust and Innovative Vaccine Effectiveness DRIVE aims at developing a governance model between public and private... -
TransQST
TransQST aims to develop novel computational approaches using the best available data from the public and private domains... -
HARMONY
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONY aims at capturing, integrating, analysing and harmonising... -
AMYPAD
Amyloid imaging to prevent Alzheimer’s Disease The Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) project aims at studying...
OUR PARTNERS
LATEST NEWS
-
14TH CORPORATE ANNIVERSARY
Jul 22, 2022
We’re celebrating 14 years of continuous support to complex research and development of biomedical projects. We do... -
SYNAPSE BRINGS TOGETHER THE PARTNERS AND MEMBERS OF THE SCIENTIFIC COORDINATING COMMITTEE OF THE NEURONET EUROPEAN INITIATIVE
Jul 5, 2022
Representatives of the partner organizations of the NEURONET initiative coordinated by SYNAPSE and members of its Scientific Coordination... -
EHDEN ANNOUNCES THE RELEASE OF THE EHDEN PORTAL
Jun 29, 2022
Last week EHDEN announced the first release of the EHDEN Portal, with free access to the research... -
SYNAPSE ORGANIZES THE 15TH ETRANSAFE CONSORTIUM MEETING IN BARCELONA
Jun 28, 2022
The first face-to-face meeting of the project since 2020 was held in Barcelona in June 2022, featuring the... -
SYNAPSE CO-ORGANIZES THE 5TH CONSORTIUM MEETING OF ERA4TB IN MADRID
Jun 22, 2022
Last 20th – 21st June, more than 120 representatives of ERA4TB partners met in Madrid after 2... -
SYNAPSE PARTICIPATES AT THE 9TH GENERAL ASSEMBLY MEETING OF TRANSQST
Jun 17, 2022
Inari Soininen, our Senior Project Manager, led two plenary sessions providing an overview of dissemination highlights and project... -
PRESS RELEASE: HARMONY presents new insights in prognosis of AML patients
Jun 10, 2022
Source: HARMONY Alliance website The HARMONY Alliance will present new results in Acute Myeloid Leukemia (AML) at the... -
SYNAPSE PARTICIPA EN LA XV CONFERENCIA ANUAL DE LAS PLATAFORMAS TECNOLÓGICAS DE INVESTIGACIÓN BIOMÉDICA
Jun 1, 2022
Sandra Pla, COO de Synapse Research Management Partners, ha participado hoy 1 de junio en la XV Conferencia... -
The Neuronet Coordination and Support Action releases updated Decision Tool for engagement with Regulatory and Health Technology Assessment bodies
May 9, 2022
Today, the members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme are pleased to announce the launch... -
Synapse will contribute with Project Management services to DARWIN EU® initiative
Feb 11, 2022
The Erasmus MC has been contracted by the European Medicines Agency to establish the Coordination Centre for the...